The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma

Leuk Lymphoma. 2022 Apr;63(4):903-910. doi: 10.1080/10428194.2021.2010064. Epub 2021 Nov 29.

Abstract

The Prognostic Nutritional Index (PNI), a parameter combining serum albumin concentration and absolute lymphocyte count, is considered a measure of the nutritional and inflammatory status and the host's anti-tumor response. We analyzed the clinical characteristics and outcomes according to the PNI of 351 grades 1-3 A FL patients. Forty-one patients (12%) had a PNI ≤45, who were older and showed adverse baseline features. A low PNI was associated with a shorter PFS (only for patients >60 years), and OS (for all patients, 10-year OS, 52% versus 74%, p = 0.0001). The prognostic impact of the PNI on OS was confirmed in a multivariate model for patients >60 years (HR = 3, p = 0.006). In conclusion, the PNI is a readily accessible piece of information that can identify a small subset of FL patients with shorter survival, and it could be an aid to improve the nutritional status of patients prior to treatment initiation.

Keywords: Follicular lymphoma; Prognostic Nutritional Index; chemoimmunotherapy; response; survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Humans
  • Lymphoma, Follicular* / diagnosis
  • Lymphoma, Follicular* / therapy
  • Nutrition Assessment*
  • Nutritional Status
  • Prognosis
  • Retrospective Studies
  • Survival Rate